{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:41:04Z","timestamp":1792741264221,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.017","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T15:28:08Z","timestamp":1681140488000},"page":"3019-3023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1\u00a0+\u00a01) compared to two primary doses and a booster (2\u00a0+\u00a01) in UK infants"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-5242","authenticated-orcid":false,"given":"David","family":"Goldblatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvinder K.","family":"Aley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Roalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Plested","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Litt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Waight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.017_b0005","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"NEnglJMed"},{"key":"10.1016\/j.vaccine.2023.04.017_b0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.04.017_b0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.017_b0020","doi-asserted-by":"crossref","first-page":"e1001839","DOI":"10.1371\/journal.pmed.1001839","article-title":"The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Indirect Immunity in High-Income Countries","volume":"12","author":"Flasche","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.04.017_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial","volume":"18","author":"Goldblatt","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.017_b0030","doi-asserted-by":"crossref","first-page":"e1002845","DOI":"10.1371\/journal.pmed.1002845","article-title":"Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study","volume":"16","author":"Choi","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.04.017_b0035","doi-asserted-by":"crossref","first-page":"e0195799","DOI":"10.1371\/journal.pone.0195799","article-title":"Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England","volume":"13","author":"Southern","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.04.017_b0040","article-title":"Nasopharyngeal carriage of pneumococcus in children in England up to ten years after PCV13 introduction: persistence of serotypes 3 and 19A and emergence of 7C","author":"Tiley","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.017_b0045","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2017.05.077","article-title":"Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness","volume":"35","author":"Yildirim","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.017_b0050","unstructured":"Yoshida L-MMT, Nguyen HA, Le L, Iwasaki C, Takegata M, Kitamura N, et al.. Evaluation of reduced dose PCV schedules in a naive population in Vietnam. ISPPD 12. Toronto; 2022."},{"key":"10.1016\/j.vaccine.2023.04.017_b0055","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S1473-3099(20)30289-9","article-title":"Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial","volume":"12","author":"Madhi","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.017_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cix742","article-title":"Effect of Maternally Derived Anti-protein and Anticapsular IgG Antibodies on the Rate of Acquisition of Nasopharyngeal Carriage of Pneumococcus in Newborns","volume":"66","author":"Ojal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.017_b0065","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.vaccine.2019.06.071","article-title":"Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006\u20132018","volume":"37","author":"Andrews","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.017_b0070","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S2213-2600(21)00538-5","article-title":"Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter?","volume":"10","author":"Amin-Chowdhury","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"23","key":"10.1016\/j.vaccine.2023.04.017_bib71","article-title":"Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial","author":"Olwagen","year":"2023","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:48Z","timestamp":1759404348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":15,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23004000"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1\u00a0+\u00a01) compared to two primary doses and a booster (2\u00a0+\u00a01) in UK infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}